Načítá se...
Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea
Clozapine is approved by the US Food and Drug Administration for treatment-resistant schizophrenia and mitigation of suicidality in patients with schizophrenia or schizoaffective disorder. Clozapine requires monitoring of adverse events, such as hypotension, myocarditis, cardiomyopathy, seizures, se...
Uloženo v:
| Vydáno v: | Ment Health Clin |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
College of Psychiatric & Neurologic Pharmacists
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956972/ https://ncbi.nlm.nih.gov/pubmed/31942277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2020.01.034 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|